EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Impact of Hypertension and Comorbidities on Mortality in Patients with COVID-19: A Retrospective Study

Wail A. Tashkandi

Saudi Critical Care Journal · 2024-07 · 8 (3) · 58-63

DOI: 10.4103/sccj.sccj_1_25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Saudi Critical Care Journal, online erschienen am 27.03.2026. Verfasst von Wail A. Tashkandi. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The coronavirus disease 2019 (COVID-19) pandemic has posed significant challenges to healthcare systems worldwide. Identifying preadmission predictors of mortality in COVID-19 patients is crucial for managing resources effectively and prioritizing high-risk individuals. This single-center, observational, retrospective study aimed to define the predictors of mortality in COVID-19 patients admitted to a tertiary hospital in Jeddah, Saudi Arabia.

Methods

A total of 108 adult patients with confirmed COVID-19 were included in the study, and their electronic medical records were reviewed for demographic and clinical data. Various laboratory results, including complete blood count, glycated hemoglobin, liver and renal function tests, C-reactive protein, and others, were collected at the time of admission. Multivariable logistic regression analysis was used to identify significant predictors of in-hospital mortality.

Results

The study revealed a concerning in-hospital mortality rate of 51.9%. Surprisingly, no significant associations were found between mortality and age, gender, body mass index, or nationality. Hypertension emerged as a critical preexisting comorbidity significantly associated with increased mortality risk. Patients without hypertension were nearly seven times more likely to survive COVID-19 compared to those with hypertension.

Conclusions

This study highlights hypertension as a critical factor influencing COVID-19 mortality. Identifying and prioritizing patients with preexisting hypertension can potentially help reduce the mortality rate in COVID-19 patients and aid in resource allocation during the ongoing pandemic.

Zitieren

APA

Tashkandi, W. A. (2024). Impact of Hypertension and Comorbidities on Mortality in Patients with COVID-19: A Retrospective Study. Saudi Critical Care Journal, 8(3), 58-63. https://doi.org/10.4103/sccj.sccj_1_25

Vancouver

Tashkandi WA. Impact of Hypertension and Comorbidities on Mortality in Patients with COVID-19: A Retrospective Study. Saudi Critical Care Journal. 2024;8(3):58-63. doi:10.4103/sccj.sccj_1_25

BibTeX
@article{Tashkandi2024,
  author = {Tashkandi, Wail A.},
  title = {Impact of Hypertension and Comorbidities on Mortality in Patients with COVID-19: A Retrospective Study},
  journal = {Saudi Critical Care Journal},
  year = {2024},
  volume = {8},
  number = {3},
  pages = {58--63},
  doi = {10.4103/sccj.sccj_1_25}
}
Kostenlos starten →